NFSG
OLMA icon

Newbridge Financial Services Group’s Olema Pharmaceuticals OLMA Stock Holding History

Newbridge Financial Services Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-28
Closed -$253 – 1373
2023
Q2 		$253 Hold
28
– – ﹤0.01% 1284
2023
Q1 		$97 Hold
28
– – ﹤0.01% 1362
2022
Q4 		$69 Hold
28
– – ﹤0.01% 1407
2022
Q3 		$0 Hold
28
– – ﹤0.01% 1448
2022
Q2 		$0 Hold
28
– – ﹤0.01% 1471
2022
Q1 		$0 Hold
28
– – ﹤0.01% 1520
2021
Q4 		$0 Hold
28
– – ﹤0.01% 1499
2021
Q3 		$1K Hold
28
– – ﹤0.01% 1290
2021
Q2 		$1K Hold
28
– – ﹤0.01% 1376
2021
Q1 		$1K Buy
+28
New +$1.2K ﹤0.01% 1302

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Newbridge Financial Services Group's OLMA Position: Q3 2023 in Review

Newbridge Financial Services Group sold out of Olema Pharmaceuticals (OLMA) in Q3 2023, closing a stake of 28 shares — an estimated $253 sold.

Newbridge Financial Services Group first reported a position in OLMA in Q1 2021 and held it in 10 quarters. The position peaked at $1K in Q3 2021. 97 funds tracked by Wall St. Rank hold OLMA as of Q3 2023.

  • Newbridge Financial Services Group reported no remaining Olema Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 28 Olema Pharmaceuticals shares in Q3 2023, an estimated $253.
  • Newbridge Financial Services Group first reported a position in Olema Pharmaceuticals in Q1 2021 and held it in 10 quarters.
  • Newbridge Financial Services Group's Olema Pharmaceuticals position peaked at $1K in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2023.

Based on Newbridge Financial Services Group's 13F filing for Q3 2023, filed 17 Oct 2023.